(Q43253095)

English

Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment

scientific article published on 29 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Torsten Haferlach

6

object named as

T Haferlach

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Claudia Haferlach

1

object named as

C Haferlach

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Susanne Schnittger

3

object named as

S Schnittger

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

author name string

U Bacher

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

T Weiss

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

W Kern

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

29 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

638-640

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

https://scigraph.springernature.com/pub.10.1038/leu.2009.222

0 references

Clonal evolution in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.222

21 January 2018

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.222

21 January 2018

Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.222

21 January 2018

The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.222

21 January 2018

Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.222

21 January 2018

CyDAS: a cytogenetic data analysis system

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.222

21 January 2018

Cytogenetic evolution patterns in CML post-SCT

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.222

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.222

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2009.222

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43253095&oldid=2071561491"